Skip to content

Novel Test Method for Non-Obstructive Mesenteric Ischemia (NOMI)

Evaluation of tolerability and normal baseline data collection for a novel test method for early detection of non-obstructive intestinal membrane ischemia (NOMI).

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs032230527
Enrollment
24
Registered
2023-12-21
Start date
2024-01-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients admitted to the esophago-gastrointestinal surgical ward or ICU (regardless of disease)

Interventions

Perform examination for NOMI using a novel technique with a diagnostic ultrasound system.

Sponsors

Ohira Gaku
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with suspected NOMI: Patients suspected of developing NOMI 1) Patients who have given consent to participate in this study, either by themselves or by a surrogate 2) Patients who are 20 years of age or older 3) Patients who have consulted with the Department of Esophagology and Gastroenterology, Chiba University Hospital 4) Patients with abdominal findings such as abdominal pain, abdominal distention, and any of the following (1) Worsening or new onset of circulatory failure (2) Prolonged elevation of Lactate in blood Non-NOMI patients: Control patients without organ failure 1) Patients who are 20 years old or older. 2) Patients who were admitted to the Department of Esophago-Gastrointestinal Surgery, Chiba University Hospital by walking in for scheduled surgery. 3) Patients who have obtained consent for participation in this study from themselves or their significant others.

Exclusion criteria

Exclusion criteria: 1) Patients who are unable to perform ultrasound examinations due to inability to carry the equipment to the bedside. 2) Patients who are pregnant, possibly pregnant, within 28 days postpartum, or breastfeeding 3) Patients who are deemed by the physician to be inappropriate for the safe conduct of this study 1) Patients with abdominal symptoms on admission 2) Patients who cannot walk independently

Design outcomes

Primary

MeasureTime frame
Tolerability of new testing methods

Secondary

MeasureTime frame
Detection rate in each organ

Contacts

Public ContactSatoko Arai

Chiba University Hospital

arai-satoko@chiba-u.jp+81-43-222-7171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026